Anticancer microrna and lipid formulations thereof
US2020352978A1
Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
EP3800256A1
Combination to be used in therapeutic use against diseases or conditions associated with melanoma, or in diseases or conditions associated with activated b-raf pathway
US2015225716A1
MiRNA for treating head and neck cancer
EP2663641A1
Mirna for treating diseases and conditions associated with neo-angiogenesis
EP3369817A1
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma , or in diseases or conditions with activated braf pathway
EP3214174A1
A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt
